Page 1 of 29
Tender for Testing of Drugs for The Year 2013-2015
CENTRAL STORES
DIRECTORATE (MEDICAL) DELHI
ESI DISPENSARY COMPLEX
TILAK VIHAR, NEW DELHI-110018
Phone No.28335358 & 28335360, Fax 28335357
www.esic.nic.in & www.dmdesic.nic.in
DMU-16/55/RC/Testing of drugs/2013/CS
Subject:
Dated ………2013
Invitation of tender and Instructions to Tenderers.
Note: The envelope containing the tender as well as subsequent
Communications should be addressed and delivered to:
The Director (Medical) Delhi, E.S.I. Dispensary Complex
Tilak Vihar,New Delhi- 110018.
All communications must be addressed to the officer named
above by title only and not by name.
From
:
The Director (Medical) Delhi
ESI Dispensary Complex
Tilak Vihar,New Delhi-110018.
To
M/s. _________________________________
_________________________________
_________________________________
Dear Sir/Madam
I invite the tender for the testing of Drugs as per the items
detailed in schedule attached. The conditions of the contract which
will govern any contract made are given here under and in the general
conditions of the contract (Annexure – I) and special instructions
(Annexure – II) attached to this tender invitation. If you are in a
position to quote for testing of drugs in accordance with the
requirements stated in the attached schedule. Please submit your
quotation to this office.
1.
SIGNING OF TENDER
Individuals signing tender or other documents connected with
the contract specify:(i) Whether signing as a "Sole Proprietor" of the firm
or his attorney.
Page 2 of 29
(ii) Whether signing as a "Registered Active Partner" of
the firm or his attorney.
(iii) Whether signing for the firm "Per Procurationem."
(iv) In the case of companies and firms registered under
the Indian
Partnership
Act the capacity in which
signing, e.g.Secretary, Manager, Partner etc. or their
attorney and produce copy of document, empowering him to do
so, if called upon to do so.
Note: In case of unregistered firms all the members or
all attorneys duly authorised by all of them or the Manager of
the firm should sign the tender and subsequent documents.
2.
PERIOD FOR WHICH THE OFFER WILL REMAIN OPEN
The quotation shall remain open for a period of one year from
the date of opening of tender.
3.
Director (Medical) Delhi/Medical Superintendent, ESI Hospital
New Delhi does not pledge himself to accept the lowest or any
tender and reserves the right of accepting the whole or any
part of the tender. after complete formalities required for the
formal acceptance of the tender and will be forwarded to the
tenderer as soon as possible and the instruction contained in
the communication should be acted upon immediately.
Acceptance of tender by competent authority will be
communicated by a letter of acceptance after completion of
formalities required for the formal acceptance of the tender
and will be forwarded to the tenderer as soon as possible and
the instruction contained in the communication should be acted
upon immediately.
Yours faithfully,
Director (Medical) Delhi/Medical Superintendent
ESI Corporation
Page 3 of 29
ANNEXURE-I
GENERAL CONDITION CONTRACT
1.
DEFINITIONS:
In the interpretation of the contract and the general and /or special
condition governing it, unless the context otherwise requires:(a) The term 'Contract shall mean the invitation to
tender, the instructions to tenderer acceptance of the tender
schedule, particulars" hereinafter defined and those general and
special conditions that may be added.
(b) The term "Contractor" shall mean the person,
firm or Company with whom the order for drug testing is placed and
shall
deem to include the contractor's
successor (approved
by the
purchaser) representatives, heirs, executors and
administrators
unless excluded by the contract.
(c) 'Contract price' shall mean the price of tests accepted
or the prices calculated in accordance with the prices accepted by
or on
behalf or of the purchaser.
(d) The term "delivery" shall mean delivery of reports by
the dates specified in the acceptance of tender of drug testing
(e) The term "Corporation" shall means the Employees"State
Insurance Corporation.
(f) The
term
Director
(Medical)Delhi/Medical
Superintendent, ESI Hospital and any other officer authorised for
the time being in the administration of ESI Corporation and any
other officer authorised for the time being to execute contract
relating to the drug testing on behalf of the purchaser.
(g) The term “Purchaser” shall mean purchaser or purchasers
named in the schedule to tender, his or their successors or assignees.
(h) The term "test" shall mean such test or tests as are
prescribed by the specification or considered necessary by the
purchaser.
2.
Authority of person signing document:
A person signing the tender Form or any documents
forming part of the contract on behalf of another shall be deemed to
warranty, that he has authority to bind such other and if, on
enquiry, it appears that the person so, signing had no authority to
do so, the Director (Medical)Delhi/Medical Superintendent, ESI
Hospital may without prejudice to other Civil and criminal remedies
Page 4 of 29
cancel contract
damages.
and held the
signatory
liable
for all
cost and
3. RESPONSIBILITY FOR EXECUTING CONTRACT
The Contractor is to be entirely responsible for the execution of the
contract in all respects in accordance with the Terms and conditions
as specified in the acceptance of tender and the schedule
annexed there-to.
4.
SUBLETTING OF CONTRACT:
The Contractor shall not sublet, transfer or assign the
contract or any part thereof without the written permission of
the
Director (Medical)Delhi/Medical Superintendent. In the event of
the
contractor
contravening
this
condition
the
Director
(Medical)Delhi/Medical Superintendent, be entitled to place the
contract elsewhere on the contractors account at his risk and the
contractor shall be liable for any loss or damage with the Director
(Medical)Delhi/Medical Superintendent ESI Hospital, may sustain in
consequence of arising out of such replacing of the contract.
5.
EARNEST MONEY:
The tenderer shall have to deposit Earnest Money Rs.
5000.00 as per terms and condition of tender In the event of
withdrawal/revocation of tender before the date specified for
acceptance, the Earnest Money shall stand forfeited.
6.
SECURITY DEPOSIT:
In case selected, EMD will be kept as security deposit.
Performance security is required to protect the purchaser against the
risk of the contractor’s conduct which would warrant the forfeiture of
the performance security. Performance security of the contractor will
be forfeited, if the contractor withdraws or amends without prior
consent or impairs or derogates from the tender in any respect with
the period validity of rate contract or if it comes to notice that
information documents furnished is incorrect, false, misleading or
forged without prejudice to other right of the purchaser. The
performance security will also be forfeited without prejudice to other
right of the purchaser if it fails to furnish the required performance
with in the specified period (validity period).
7.
Recovery of sums due: Whenever any claim for the payment
of a sum of money arises out of or under this contract against
the contractor the purchaser shall be entitled to recover of such sum
by appropriating, in part or whole the security/earnest money
deposited by the contractor, if a security/earnest money is taken
against the contract. In the event of the security/earnest money
Page 5 of 29
being insufficient or if no security/earnest money has been
deposited by the contractor, then the balance or the total sum to be
recoverable, as the case may be shall be deducted from any sum then
due or which at any time thereafter may become due to contractor
under this or any other contract with the purchaser. Should this
sum not be sufficient to cover the full amount recoverable, the
contractor shall pay to the purchaser on demand the remaining balance
due.
8. Insolvency and Breach of Contract:
The Director (Medical) Delhi/Medical Superintendent may
at any time by notice in writing summarily terminate the contract
without
compensation to the contractor in any of the following
contingencies, that is to say:(i) If the contractor being an individual or if firm,
any partner in the contractor's firm, shall at any time be
adjudged insolvent
or shall
have a
receiving
order or
orders for administration of his estate made against him or
shall take any proceedings for liquidation or composition under any
insolvency Act for the time being in force or shall make any
conveyance or assignment of this effects or enter into any
arrangements or composition with his creditors or suspend payment or
if the firm be dissolved under Partnership Act, or
(ii) If the contractor being a company
shall pass a
resolution or the courts shall make an order for the liquidation of
the affairs or a receiver or Manager on behalf of the debenture
holder shall be appointed or circumstances shall have arisen
whichentitled the court or debenture holders to appoint a receiver
or Manager, or
(iii) If the contractor commits any breach of this contract not
herein specifically provided for:
Provided always that such
determination shall not
prejudice any right of action or remedy which shall have accrued or
shall accrue thereafter to the purchaser and provided also that the
contractor shall be liable to pay the purchaser for any extra
expenditure he is thereby put to but shall not be entitled to any
gain on repurchased.
9.
Arbitration :-
In the event of any question, dispute or
difference arising under these conditions or any special conditions
of contract, or in connection with this contract, except as to nay
matter the decision of which is specially provided for by these on
Page 6 of 29
the special conditions the same shall be referred to the sole
arbitration of the Director (Medical )Delhi/Medical Superintendent
or some other person appointed by him. It will be no objection that
the arbitrator is a Government servant, that he had to deal with
the matter to which the contract relates for that is the course of
his duties as a Government Servant he had expressed views on all or
any of the arbitration
dispute or difference. The award of
the arbitrator shall be final and binding on the parties to the
contract.
It is a term of the contract:(a) If the arbitrator be the Director(Medical)Delhi/Medical
Superintendent ESI scheme:
(i) In the event of his being transferred or
vacating his office by resignation or otherwise, it shall be lawful
or his successor in-office either to proceed with the reference
himself or to appoint another person as arbitrator: or
(ii) In the event of his becoming unable to act, for
any reason it shall be lawful for Director (Medical)Delhi/Medical
Superintendent to appoint another person as arbitrator.
(b) If the arbitrator be a person appointed by the Director
(Medical) Delhi/Medical Superintendent
In the event of his dying, neglecting or refusing to act, being
unable to act, for any reasons in shall be lawful for the Director
(Medical )Delhi/Medical Superintendent either to proceedwith the
reference
himself or to appoint another person as arbitrator
in place of the outgoing arbitrator.
It is further a term of this contract that no
other than the Director
General,
Employees"
Corporation or the person appointed by him should
and that, if for any reason that is not possible,
to be referred to arbitrator at all.
person
State Insurance
act as arbitrator
the matter is not
Upon every and such reference, the assessment of the
costs incidental to the reference and award respectively shall be in
the discretion of the arbitrator.
Subject as aforesaid the Arbitrator Act, 1940 and
the rules there under and any statutory modifications thereof for
the time being in force shall be deemed to apply to the arbitrator
proceedings under this clause.
Work under the contract shall, if reasonable possible
continue during the arbitration proceeding and no payment due to
Page 7 of 29
payable by the
proceedings:-
purchaser
shall
be
withheld
on
account
of
The venue of arbitration shall be Delhi.
In this clause the expression," the Director General,
Employees' State Insurance Corporation” means the Director (Medical)
Delhi/Medical Superintendent ESI Scheme for the time being and
includes, is there be no Director (Medical )Delhi/Medical
Superintendent,
the
officer who is for the time being the
administrative head of the Employees' State Insurance Corporation,
whether in addition or otherwise.
For the purpose of the contract including arbitrator proceedings
there under, the Director(Medical)Delhi/ Medical Superintendent
Hospital shall be entitled to exercise all the
rights and Powers of the purchaser.
ESI
Fraud & Corruption
The bidder, supplier, contractor and the consultants observe the
highest standard of ethics during the procurement & execution of such
contracts in pursuit of this:
a) Defines, for the purposes of this provision, the terms set forth
below as follow:i.
“Corrupt Practice” means the offering, giving, receiving or
soliciting directly or indirectly of anything of value to
influence the action of public official in the procurement
process or in contract execution.
ii.
“Fraudulent Practice” means a misrepresentation or omission
of facts in order to influence a procurement process or the
execution of a contract.
iii.
“Collusive Practice” means a scheme or arrangement between
two or more bidders, with or without the knowledge of the
borrower, designed to establish bid prices at artificial,
non competitive levels; and
iv.
“Coercive Practices” means harming or threatening to harm,
directly or indirectly, person or their property to
influence their participation in the procurement process or
affix to execution of a contract.
b) Will reject a proposal for award if it determines that the bidder
recommended for award has, directly or through an agent, engaged
in corrupt, fraudulent, collusive, coercive practices in
competing for the contract in question.
Page 8 of 29
ANNEXURE -II
To
the
Tender
INSTRUCTIONS
invitation
____________________ SPECIAL
1.
Tenderers are requested to submit their quotations on
fixed price basis.
2. Price quoted should be inclusive of testing charges,
collection of samples as well as delivery of reports F.O.R.
destination in Indian Currency. Tenders not complete in this
respect are liable to be ignored.
3. The contractor shall, wherever, called upon to do so give
full information with reference to govt. institutions to which
services are rendered and shall also permit the Director (Medical
)Delhi/ Medical superintendent or any other officer nominated
by him to inspect the premises of the tenderer at all reasonable
times and shall give all assistance and information as may be
required by him in connection with the contract.
JURISDICTION
4. All questions, disputes or difference arising under or out of
or in connection with the contract, if included shall be settled
by sole Arbitration of Director (Medical)Delhi, Employees State
Insurance Scheme or a person appointed by him in this behalf .
INSPECTION AUTHORITY
5. The Director (Medial) Delhi or the Agent/Inspector nominated by
him shall be the inspecting authority.
6. It may be noted that the unsuccessful tenderer will not be
informed about the result of his tender.
Page 9 of 29
Annexure-III
Forwarding letter of the firm (On Firm’s Letter Head)
From
______________________________
________________________________
________________________________
To
Director (Medical) Delhi,
Directorate (Medical) Delhi,
ESI Dispensary Complex,
Tilak Vihar, New Delhi-110018
Sub: Testing of drugs at the quoted rate to Director (Medical)
Delhi, for the period of Two years i.e. 2013-2015
Sir,
M/s. I/We/am/are authorized signatories of
I/ we hereby undertake as follows:1.
I/we hereby undertake to do testing of drugs mentioned in
Annuxure ‘A’ in areas
specified
by
the
Director
(Medical)
Delhi, ESI Dispensary Complex, Tilak Vihar for the period of Two
years at the rates
quoted by me/us in the prescribed tender
form, which is submitted herewith according to the instructions
and the terms and conditions. The duration of the said contract
may be extended on the same terms and conditions & rates if the
Director(Medical)Delhi so desires.
2.
The rates quoted against each testing items by me/us in
the tender are inclusive of all service charges, transportation
charges and duties/taxes payable during the contract period.
3.
Necessary documents as required are enclosed herewith in
the order in which they are mentioned.
4.
I/we
understand
that
security deposit submitted on
entering into contract, is likely to be forfeited in the event
of lapse on my/our part to comply with the terms and conditions
of
the
tender
if proven to have followed
unscrupulous
practices apart from the liability of penal action for violating
the law of the land.
Page 10 of 29
5. I/we have carefully read and understood the terms and
conditions to avoid any error, omission. I/we shall abide by
these conditions. I/we will follow them very scrupulously.
6. My/our firm has not been blacklisted by any other Govt.
institution/ Organisation during the last three years.
7. I/we also take cognizance of the fact that failure to
furnish the information called for by the Director(Medical)
Delhi or to comply with any requirements laid down under the
conditions
will be
considered
as disqualification and
the tender by rejection on that account
8. I/we undertake to abide by the instructions
Director (Medical) Delhi from time to time.
issued by the
9. In case of my report declared wrong by any Govt./Govt.
approved agency I/we am/are liable for appropriate action.
10. The rate quoted by me/us will not be higher than the rate
quoted by me/us to any Govt. Institution/agency with in Govt.
of NCT of Delhi/Noida region during the contract period.
I/we hereby undertake to abide by the terms and conditions of the
contract modified from time to time and I/we have signed all the
papers of terms and conditions and filled up prescribed Performas
given along with the tender.
Yours faithfully,
(Signature of tenderer with stamp)
(Authorized Signatory)
Page 11 of 29
Annexure-IV
CENTRAL STORES
DIRECTORATE (MEDICAL) DELHI
ESI SCHEME: ESI DISPENSARY COMPLEX:
TILAK VIHAR: NEW DELHI-110018
INSTRUCTIONS SUPPLEMENT/ TERMS AND CONDITIONS FOR RATE CONTRACT of
TESTING OF DRUGS (2013-2015)
Sub: Tender Enquiry-Rate Contract for Testing of Drugs for ESI Scheme
in Delhi & NOIDA.
1.Sealed Tenders are invited in single bid system on behalf of
Director (Medical)Delhi,ESI Corporation for the formation of
Rate Contract for two years (2013- 15) from Govt.approved firms
for testing of drugs as per specification detailed in
(Annexure-A).
2.Tender document can be obtained from the office of Dy.
Manager(Stores), Central Store, ESI Dispensary Complex, Tilak
Vihar, New Delhi-110018 on any working day between 10.00AM to
1.00 PM up to 09.01.2014. Against the payment of Rs.200/- (Rs.Two
Hundred Only Non-refundable) in the form of Demand
Draft/Bankers Cheque in favour of ESIC Fund Account No.1
Payable at New Delhi.
3. Tender document can be downloaded from ESIC Website
www.esic.nic.in & www.dmdesic.nic.in
4. Those who are downloading the tender document from website
should submit Rs 200/-(RS. Two Hundred Only Non-refundable)as
Tender Cost in the form of Demand Draft/Bankers Cheque in
favour of ESIC Fund Account No.1 Payable at New Delhi along
with tender documents.
5. Sealed Tender Form (Covering Enevelope)complete in all
respect signed with stamp of the firm on each page should be
dropped in the Tender Box kept in chamber of
Dy.Manager(Stores) at Central Stores upto 1.00P.M. on
09.01.2014.The tender will be opened at 2.30PM on 09.01.2014(the
same day) .If 09.01.2014 is declared a holiday,tender will be
opened on the next working day at same time. Tender received
late
will
not
be
entertained. Tenderer/Representative
may attend the tender opening process.
6. Earnest Money of Rs.5000/-(Five thousands only)is to be
deposited
either through Banker's cheque or Demand Draft in
favour of "ESIC fund Account No.1".The EMD deposited with
earlier tenders will
not be adjusted against this tender.
Tenders without EMD will not be entertained
Page 12 of 29
7.
The Rate Contract will be valid for Two years from the date
of finalisation of the tender. The
duration of said
contract may be extended on the same terms and conditions
and rates if Director (Medical) Delhi so desires .
8. Samples of Drug testing shall be given to the selected
tenderers on rotation and if samples are not collected by the
assigned tenderer on the day allotted,sample will be given to
next tenderer or in rotation.
9. Samples must be collected from central store, ESI Dispensary
Complex, Tilak Vihar, New Delhi 110018 at least once a week
or as desired by purchaser at cost and risk of the firm.
10. Reports must be submitted within the period as specified by
the laboratory. The cut off date of submission of report shall be
from the 3rd day (third day) of actual submission of report. For
non submission of reports of the drug testing on time, the
tenderer shall be liable to pay 5% (Five percent) of the value of
test as penalty per week up to a maximum of 10% (ten percent). if
the REPORT of sample collected is not submitted even after two
weeks then the items will be tested from next higher bidder
and the difference will be recovered from subsequent
bills/security money deposit.
The cut off date of delivery of report shall be counted from
the date of actual dispatch of samples given to representative
of
laboratory. The extra expenditure involved in testing of
drugs will be recovered in full from the firm at the discretion
of the competent authority. The risk purchase so imposed will be
payable by the firm or will be deducted from the incoming
bill(s)/ security money of the firm.
11. List of govt. institutes to be provided for which such
services are provided by testing laboratory.
12. An undertaking that the testing charges are not more than the
rates charged from other institutions.
13. Copy of valid license for carrying out testing of drugs from
appropriate authority.
14. Testing charges are to be mentioned inclusive of all taxes
including service charges/Transportation charges in numerical &
words.
15. The rates should be applicable for ESI Scheme Delhi & Noida.
16. Payment shall be made within a month after submission of
reports & bills.
Page 13 of 29
17. Copy of valid documents in support of registration of
VAT/Service Tax and PAN.
18.
Tenderer must quote the rates strictly as per the given
Format (Hard Copy).
Table-I
S.
Name of the
Quantity of
Time required for
Rate per
Rate per test
No.
Items
drugs
delivery of reports
test ( in
(in words)
required for
figure)
testing
19. Tenderer must submit a copy of quoted rates in CD in Excel
Format.
20. Each page of the tender form should be numbered. All the
papers in tender form must be completely signed and stamped along
with terms and conditions.
21. Tender should be typed. The rates should be quoted in
figures as well as in words without any overwriting/cutting/
erasing.IN CASE THERE IS ANY OVERWRITTING /ERASING/CUTTING AND
ANY DISCREPENCY IN RATES IN WORDS AND FIGURES THE ITEM WILL NOT
BE CONSIDERED.
22. Telegraphic/telex/fax/email/conditional/incomplete tenders
will not be entertained and shall be rejected out rightly.
23. Tenderer must quote the rates strictly as per our list of
items attached with the tender form mentioning the serial no. of
item.
24. The tenderer should also submit an undertaking that all the
Terms & Conditions of the Tender are acceptable in complete.
25. Tenderer must be in business for three years w.e.f 2010 in
this business which should be supported by undertaking on the
Firm’s Letter Head as per enclosed format i.e. Annexure-V.
26. The tenderer should also submit an undertaking that the
quoted items have not been & are not being tested for any other
organisation at rates lower than being quoted here.
27.
not
The tenderer should submit an Undertaking that the firm is
blacklisted in any Govt. Organisation/Institution.
28.
Security Deposit:
In case selected, EMD will be kept as security deposit.
EMD of unsuccessful tenderer will be returned without
any interest
within one month after the award of
contract. The tenderer should enclose a pre-receipt to this
29.
Page 14 of 29
30.
as per Annexure "B".
Security of successful tenderer will be returned
without any interest on receipt of satisfactory
performance report from user departments after the expiry
of rate contract.
31. a) Withdrawal of tenders’ along with the earnest money will
be allowed before the opening of tender.
After opening of tender:I) Withdrawal of the complete tender can be allowed but in
such cases, the earnest money will be forfeited.
II) No change / alteration in rate or other terms in the
tender will be permitted under any circumstances.
III) Partial withdrawal (in respect of one or more items
quoted) will not be allowed under any circumstances.
b) There will be no correspondence between the tenderer and
the DIRECTOR (MEDICAL) DELHI till the tender is finalized.
32.
Samples
will
be
given
to
tenderer/authorized
representatives and reports will be accepted accordingly.
33.
All the disputes relating to this tender inquiry and
Rate Contract shall be subject to the territorial
jurisdiction of courts at Delhi/New Delhi only.
34.
The DIRECTOR (MEDICAL) DELHI reserves the right to accept
or reject any or all the tenders without assigning any
reason (s) thereof and have the right to place order on
one or more firms.
35.
a)
b)
c)
The tender will be rejected if:Conditional Tender is submitted.
All the papers are not complete.
Tender is not sealed properly.
36. The Item quoted will be rejected if:a) More than one type of rates is quoted for one product.
b) The rates quoted are not found same both in figures and
words.
DATES:- LAST DATE OF SUBMISSION OF THE TENDER IS 09.01.2014 up to 1.00PM
- OPENING OF TENDER IS 09.01.2014 at 2.30PM
Director (Medical) Delhi
ESI Corporation
Page 15 of 29
ANNEXURE-“A”
List of items
S. No.
1
Name of the Items
BIFILAC SACHET(0.5GM CONT:STREPTPCOCCUS FAECALIS 30 MIL.,CLOSTRIDIUM
BUTYRICUM 2MIL.,BACILLUS MESENTERICUS 1 MIL.,LACTIC ACID BAC.50MIL)
2
C-1BILLION C.F.U OF LACTOBACILLUS RHAMNOSUS GR-1, LACTO.REUTERI RC-14
(ECOFLORA)
3
C-ANTIOXIDANT (ANTOXYL FORTE FORMULA)
4
C-BIFILAC(PRE & PROBIOTIC)STREPTOCOCCUS FAECALIS 30MIL, CLOSTRIDIUM
BUTYRICUM 2MIL, BACILUS MESENTERICUS 1MIL, LACTIC ACID BACILUS SPOR.
50MIL)
5
6
7
8
9
C-CEFACLOR 500MG (DISTACLOR)
C-CYCLOSERIN 250 (MYSEP)
C-DEXTROPROPOXEPHEN 65MG + ACETAMINOPHEN 400MG (PROXYVON)
C-ESSENTIAL L (FORMULA)
C-FENOVERINE 100MG(SPASMOPRIV)
10
11
12
C-FERROUS FUMARATE 200MG+ CYANCOBNALAMIN 15MCG + FOLIC ACID 1.5MG
(HEMSYNERAL TD)
C-IMATINIB MESYLATE 100MG (GLIVEC 100MG)
C-INDINAVIR 400MG
13
C-KARVOL PLUS (CAMPHOR 25MG, EUCALYPTOL 125MG, CHLOROTHYMOL 5MG,
MENTHOL 55MG, TERPINEOL 120MG)
14
15
16
C-LITHIUM CARBONATE-300MG
C-NATURAL MICRONISED PROGESTRONE 100MG (DUBAGEST)
C-RIFAMPICIN 600MG
17
C-SPASMOPROXYVON FORMULA(DICYCLOMINEHCL 10MG + DEXTROPROPOXYPHENE HCL 65MG + ACETAMINOPHEN 400MG
18
19
20
21
22
C-SUNITINIB MALATE 50MG (SUTENT)
C-TEMOZOLAMIDE 250(TEMODAL)
C-TETRACYCLIN 250MG
C-VITAZYME
C-ZIDOVUDINE 100MG
23
D-ALEX + PAED. DROPS(PHENYLEPHRINE HCL. 2.5MG, CHLORPHENIRAMINE
MALEATE 2MG PER ML)
24
D-AZELASTINE 0.05% EYE DROPS (OCULAST)
25
D-BETAMETHASONE SOD. PHOS. 0.1%, NEOMYCIN SULPHATE 0.5% W/V (BETNESOL-N)
EYE DROPS
26
27
28
D-BETOXALOL 0.5% EYE DROPS
D-CETRIZINE HCL 10MG/ML DROPS
D-CHLORAMPHENICOL 5%, BENZOCAINE 1% EAR DROPS (BIOMYCETIN)
29
D-CHLORAMPHENICOL 5%, LIGNOCAINE 2%, BECLOMETHASONE DIP. 0.025%
CLOTRIMAZOLE 1% EAR DROPS (CIROBIOTIC/OTEK AC)
Page 16 of 29
30
D-CLOTRIM. 1% + LIGNOCIANE 2% EAR DROPS (CANDID)
31
D-COLIMEX FORMULA( 1ML CONT: DICYCLOMINE HCL 10MG+ ACTIVATED
DIMETHICONE 40MG)
32
33
D-CYCLOPENTOLATE 1% EYE DROPS
D-DORZOLAMIDE 2%+TIMOLOL 0.5% EYE DROPS (MISOPT)
34
D-HEPATOGLOBINE DROPS (PEPTONISED IRON 117.67MG EQV. TO 20MG OF
ELEMENTAL IRON, PROTEIN AS PEPTONE 30MG, F.A. 200MCG, VIT.B12 4MCG,
PALATABLE BASE QS.
35
36
37
38
39
D-NATAMYCIN 0.5% W/V EYE DROPS
D-PREDNISOLONE ACETATE 1% EYE DROPS
D-TIMOLOL 0.5% (GLUCOMOL EYE DROP)
D-TRAVOPROST 0.004% EYE DROPS (TOVAXO)
D-TROPICAMIDE 1% EYE DROPS
40
D-WAX SOFTNER EAR DROPS (ANTIWAX) PARA DICHLOROBENZENE 2% W/V,
BENZOCAINE 2.7 W/V, CHLORBUTOL 5%, TERPENTINE OIL 15% W/V
41
D-ZINCULA EYE DROPS(BORIC ACID 80%, SOD.CH. 0.85%, NAPHAZOLINE HCL 0.02%,
ZINC SULPHATE 0.10%, PHENYL ETHYL ALCOHOL 0.50%)
42
EACH SACHET 0.67GM= WATER SOLUBLE AZULENE(SOD. AZULENESULFONATE) JPC
2.01MG L-GLUTAMINE JPC 663.30MG
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
I-5 FLU-URACIL 250MG
I-ACECLOFENAC 150MG/ML
I-AMOXY.250MG & CLAVULANIC ACID 50MG
I-AMOXYCILLIN 500MG & CLAVULENIC ACID 100MG
I-ATRACURIUM BESYLATE 10MG/ML
I-ATROPINE SULPHATE 0.6MG/1ML
I-AVASTIN 100MG (BEVACIZUMAB)
I-BEPLEX FORTE(B. COMPLEX)2ML. AMP
I-BETAMETHASONE 4MG/ML
I-BLEOMYCIN 15MG
I-BUPIVACAINE HCL 0.25%
I-BUPIVACAINE HCL 0.5% (BUPIVACAINE HEAVY) VIAL
I-CAPD LOW CALCIUM 2.5% (2LTR.)
I-CAPD LOW CALCIUN 1.5% (2LTR.)
I-CARBOPROST 0.25MG/ML (PROSTODIN)
I-CEFOTAXIME 500MG + SULBACTAM 250MG
I-CHLORAMPHENICOL 1G
I-CISPLATINUM 10MG
I-CISPLATINUM 50MG
I-CLARITHROMYCIN 500MG
I-CYCLOPHOSPHAMIDE 200MG
I-CYTOSINE ARABINOSIDE 100MG
I-DALTEPARIN SODIUM 2500IU (FRAGMIN 2500)
I-DALTEPARIN SODIUM 5000IU (FRAGMIN 5000)
Page 17 of 29
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
I-DESOFERRAXAMINE 500MG (DESFERAL)
I-DIAZEPAM 5MG/ML
I-DICLOFENAC SOD. 25MG/ML(VOVERAN)
I-DICYCLOMINE 10MG/2ML
I-DOCETEXAL 80MG
I-ENOXAPRINE SOD. 20MG/0.2ML
I-EPIRUBICIN 10MG
I-EPIRUBICIN 50MG
I-EQUINE RABIES IMMUNOGLOBULIN 1500
I-ERYTHROPOETIN 2000 IU (RECOMBINANT HUMAN ERYTHROPOIETIN)
I-ERYTHROPOETIN 3000 IU (RECMBINANT HUMAN ERYTHROPOIETIN)
I-ETHAMSYLATE 125MG/ML
I-ETOPSIDE 100MG
I-GLYCOPYROLATE 0.2MG/ML
I-HALOPERIDOL 5MG (SERENASE)
I-HEPATITIS B 10MCG PAED. (S.DOSE) 0.5ML
I-HEPATITIS B 20MCG (MULTI DOSE) 10ML
I-HEPATITIS -B 20MCG ADULT(S.DOSE) 1ML
I-HERCEPTIN 440MG (TRASTUZUMAB)
I-HUMAN CHORIONIC GONADOTROPIN 10000IU (PROFESSI)
I-HUMAN CHORIONIC GONADOTROPIN 2000 IU(PROFASSI)
I-HYDROXY PROGESTERONE 250MG (PROLUTON DEPOT-250MG)
I-HYDROXY PROGESTERONE 500MG (PROLUTON DEPOT)
I-HYLASE (HYALURONIDASE 1500UNITS)
I-IMIPENEM 500MG + CILASTATIN 500MG PER VIAL (CILANEM)
I-INSULIN GLARGINE 100UNITS/ML
I-INTERFERON ALPHA 2B 3MIL IU( INTALFA 3MIU)
I-IRON SORBITOL CITRIC ACID COMPLEX 50MG
I-LIGNOCAINE 2% (XYLOCAINE)
I-LIGNOCAINE 21.3MG WITH ADRENALINE 0.005MG PER ML
97
I-LIGNOCAINE 21.3MG,SODIUM CHLORIDE 6MG, WATER FOR INJECTION TO MAKE
1ML (XYLOCARD 2% IV)
98
99
100
101
102
103
104
105
106
107
108
I-LORNOXICAM 8MG PER 2ML VIAL
I-MAGNESIUM SULFATE 50% PER ML
I-MAINTENANCE SOLN. FOR PAED USE(ISOLYTE-P FORMULA)
I-MANNITOL 10% + GLYCERIN 10% INFUSION
I-MEPHENTERMINE (1 ML.)
I-MEPHENTERMINE 30MG/ML (10ML VIAL)(MEPHENTINE)
I-METHOTEXTRATE 50MG
I-METHOXY POLYTHENE GLYCOL EPOETIN-BETA 50MCG (MIRCERA)
I-METHYL PRED. SOD. SUCC. 125MG (SOLUMEDROL)
I-METHYL PRED. SOD. SUCC. 500MG (SOLUMEDROL)
I-METHYL PRED. SOD. SUCC.40MG(SOLUMEDROL)
Page 18 of 29
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
I-METHYL PREDNISOLONE ACCETATE 40MG (DEPO-MEDROL)
I-METOPROLOL 1MG/ML
I-MIDAZOLAM 5MG (1ML)
I-MITOMYCIN 10MG
I-MITOMYCIN 2MG
I-NANDROLONE DECAONATE 25MG/ML (DECA DURABOLIN)
I-NANDROLONE PHENYL PROPIONATE 25MG (DURABOLIN)
I-NEOSTIGMINE(PROSTIGMINE) 0.5MG/ML
I-OFLOXACIN 100ML
I-PACLITAXEL 200MG
I-PACLITEXEL 30MG
I-PARNAPARIN 6400 (FLUXUM)
I-POTASSIUM CHLORIDE 0.15GM/ML
I-PROMETHAZINE 25MG/ML(PHENERGAN)
I-RECOMBINANT FSH 75 (FOLICULIN 75) (MENOTROPIN INJ)
I-REVIPARIN SODIUM 0.6ML PFS
I-REVIPARINE SOD. 6ML MDV
I-RITUXIMAB 100MG(MEBTHERA)
I-RITUXIMAB 500MG(MEBTHERA)
I-SOD. CHLORIDE 0.9% (NORMAL SALINE)
I-SOMATROPIN (R-DNA ORIGIN) 18IU (HUMAN GROWTH HORMONE)
I-SOMATROPIN (R-DNA ORIGIN) 4IU (HUMAN GROWTH HORMONE)
I-SOMATROPIN 16 IU (R-DNA ORIGIN) (HUMAN GROWTH HARMONE)
I-TEICOPLANIN 400MG
133
I-TISSEEL KIT(ANTI COAGULANT)(TWO COMPONENT FIBRIN SEALED WITH FAST 7
SLOW SETTING OF HUMAN THROMBIN)
134
135
136
137
138
139
I-TRANSXEMIC ACID 500MG/5ML (XAMIC)
I-VALETHAMATE BROMIDE 8MG/ML (EPIDOSIN)
I-VECURONIUM 4MG/AMP (NORCURON)
I-VINCRISTINE 1MG
I-VITAMIN K 1.0MG(0.5ML AMP)
L-CHLORHEXIDINE GLUCONATE SOLN 2.5%, ETHYL ALCOHOL 70%
140
L-CHOLINE SALICYLATE 9% W/V, BENZALKONIUM CHLORIDE 0.02% GEL (ZYTEE RB)
141
142
143
144
145
146
L-CLOTRIMAZOLE 1% IN PROPYLENE GLYCOL, GLYCERIN BASE (MOUTH PAINT)
L-CLOTRIMAZOLE 1% W/W+BECLOMETHASONE DIPROPIONATE 0.025% W/V BASE
L-CLOTRIMAZOLE 10MG/ML (CANDID)
L-COALTAR 4.25% + SALICYLIC ACID SOLN. 2% LOTION
L-GAMMA BENZENE HEXA CHLORIDE 1% LOTION
L-HYDROGEN PEROXIDE
147
L-LIDOCAINE 1%, CETRIMIDE 0.1%, POLYVINYL POLYMER 2.8% (LIDOCAINE SPRAY)
148
L-SURGICAL SPIRIT
Page 19 of 29
149
150
151
152
153
154
155
156
L-TOPICAL LIGNOCAINE 4% (XYLOCAINE)
N-BECLOMETHASONE DIPROPIONATE 100MCG (BECLATE INHALER 100MCG)
N-BUDENOSIDE NASAL SPRAY 100MCG
N-FLUTICASONE 50MCG, SALMETEROL 25MCG INHALER (SERFLO 50 CFC FREE)
N-IPRATROPIUM 20MCG, LEVOSALBUTAMOL 50MCG INHALER (DUOLIN INHALER)
N-IPRATROPIUM 20MCG+SALBUTAMOL 100MCG( DUOLIN OF INHALER)
N-IPRATROPIUM BROMIDE 20MCG (IPRAVENT INHALER)
N-SALBUTAMOL 100MCG (ASTHALIN INHALER)
157
N-SALBUTAMOL 100MCG + BECLOMETHASONE DIPROPIONATE 50MCG (AEROCORT
INHALER)
158
159
O-ACYCLOVIR 3% EYE OINT
O-ADAPALENE 0.1%+CLINDAMYCIN 1%W/W (ADACIN/DERIVA CMS)
160
O-ANOVATE FORMULA(BECLOMETHASONE DIPROPIONATE 0.025%,
PHENYLEPHERINE HCL 0.1%, LIGNOCAINE HCL 2.5%)
161
O-ATROPINE SULPHATE 1% OINT.
162
O-COTARYL CREAM (FORMULA: LACTIC ACID 6%, GLYCINE 3%, AMM.CL
0.5%,SOD.CL.0.5%, POT.CL. 0.5%, CAL LACTATE 0.5%, MAG.CL 0.3%, SOD.DIHYD.PHOS.
0.5% W/V
163
164
165
166
167
168
169
170
O-DINOPROSTONE 0.5MG (CERVIPRIME GEL)
O-FERACRYLUM 1% W/W GEL (SEPGARD)
O-FLUCINOLONE ACETONIDE 0.025% (FLUCORT)
O-FLUCREME NM (FORMULA)
O-FRAMYCETIN SKIN CREAM 30GM.
O-GBHC 1% BENZOCAINE 2% CREAM BASE (SCABOMA CREAM)
O-LIGNOCAINE OINTMENT-5%
O-LIGNOCIANE 2% JELLY (XYLOCAINE )
171
O-MELACARE FORTE(HYDROQUINONE 4%+TRETINOIN 0.025% + MOMETASONE
FUROATE 0.1%)
172
O-NIMESULIDE 10MG, METHYL SALICYLATE 100MG, MENTHOL 50MG, CAPSCAICIN
0.25MG (NIZER GEL FORMULA)
173
O-SALICYLIC ACID 6%, BENZOIC ACID 12%, HYDROCORTISONE ACETATE 0.5% W/W
(KERALIN OINT. FORMULA)
174
175
176
177
178
O-SALICYLIC ACID 6%, BETAMETHASONE 0.05% (20GM)
O-ZINC OXIDE OINT. 20GM TUBE
P-ADHESIVE TAPE 10CM X 5M HYPOALLERGENIC EXTRA POROUS
P-ADHESIVE TAPE 5CM X 5M HYPOALLERGENIC EXTRA POROUS
P-ADHESIVE TAPE 7.5CM X 5M HYPOALLERGENIC EXTRA POROUS
179
P-PEGLEC (POLYETHYENE GLYCOL 118GM, POT.CL. 1.484GM, SOD.BICARBONATE
3.37GM, SOD.CH. 2.93, SOD.SULPHATE 11.36GM)
180
P-ZINC BACITRACIN 400U, POLYUMYXIN B SULPHATE 5000U, NEOMYCIN SULPHATE
3400U
181
182
R-BECLOMETHASONE ROTACAPS 100MCG
R-FLUTICASONE 100MCG ROTACAPS
Page 20 of 29
183
184
185
186
187
188
189
R-FLUTICASONE 250MG+ SALMETROL 50MCG (SEROFLO 250 ROTACAPS)
R-SALMETROL 50MCG ROTACAPS (SEROBID)
R-TIOTROPIUM BROMIDE 18MCG ROTACAPS (TIATE TRANSCAPS)
S-AMBROLITE S+(FORMULA)
S-AMOXYCILLIN 125MG + CLOXACILLIN 125MG (AMCLOX)
S-AMOXYCILLIN 200MG + CLAVULANIC ACID 28.5 MG (AUGMENTIN)
S-BECASULES SYP. (FORMULA)
190
S-BROMHEXINE HCL 8MG, TERBUTALINE SULP. 4MG, GUAPHANESIN
200MG(ASMOTONE PLUS FORMULA)
191
S-CLISTIN EXPECT.(CARBINOXAMINE MALEATE 4MG, AMMONIUM CHLORIDE 240MG,
SOD.CITRATE 240MG PER 10ML.)
192
193
194
195
196
197
S-CODEINE PHOSPHATE 10MG + CPM 4MG PER 5ML
S-CYCLOSPORIN 100MG/ML
S-DIGENE GEL/MAGLUGEL-F
S-DOMPERIDONE SUSPN.(1MG/ML)
S-ETOPHYLLINE 46.5MG + THEOPHYLLINE 14MG PER 5ML(DERIPHYLLIN)
S-GROVIT / VISYNERAL 200ML (FORMULA)
198
S-HIPHYLATE (THEOPYLLIN ETHANOATE OF PIPERAZINE 80MG, EPH HCL 12MG,
GUAIPHENESIN 50MG, ALCOHOL 0.55ML, ABSL.ALCOHOL CONTENT 10.44%)
199
200
201
S-IBUPROFEN 100MG/5ML
S-LACTULOSE 100ML ( EACH 15ML : LACTULOSE 10GM)
S-LEXATIVE ENEMA(GLYCERIN 15%, SOD.CHLORIDE 15%)
202
S-LIVER DISORDER SYP.(TRISOLIV) (TRICHOLINE CIT. 250MG, KALMEGH EQ.TO
ANDOGRAPHOLIDES 250MCG, SORBITOL SOLN.)
203
204
205
206
207
208
209
S-LORATADINE 5MG PER 5ML
S-MUCAINE GEL
S-NALIDIXIC ACID 300MG/5ML (WINTOMYLON)
S-NEUTROSEC FORMULA
SOD.AMINOSALICYLATE 800 (PAS GRANUL)
S-PHENIRAMINE MAL. 15MG/5ML (AVIL)
S-PIPERZINE CIT. EQV TO 0.75GM OF PIPERZINE HYDRATE PER 5ML
210
S-RELCER GEL FORMULA (5ML CONT:AL.HYD.6G+MG.HYD.80MG+ACTIVATED
DIMETHICONE 100MG+DEGLYCYCRRHIZINATED LIQUORACE EQV.TO LIQUORICE
400MG
211
212
213
214
S-SALBUTAMOL 2MG/5ML
S-SODIUM VALPROATE 200MG/5ML
S-TERBUTALINE SUPLHATE 1.5MG/5ML
S-TRICLOFOS SOD.500MG/5ML(KHUSHI)
215
S-VOLINI SPRAY (DICLO.DIETHYLMINE 1.16%, METHYL SALICYLATE 10%, LINSEED
OIL 3%, MENTHOL 5%, EXCIPIETS & PROPELLANT Q.S.100%)
216
217
218
T-ACENOCOUMAROL 1MG (ACITROM)
T-ALENDRONATE 35MG(OSTEOFOS)
T-ALENDRONATE 70MG(OSTEOFOS)
Page 21 of 29
219
220
221
222
223
224
225
226
227
228
229
T-AMIODARONE 200MG(CARDRONE)
T-AMITRIPTYLINE 25MG
T-AMOXYCILLIN 200MG+CLAVULANIC ACID 28.5MG DISP.
T-AMOXYCILLIN 250MG + CLAVULANIC ACID 125MG (AUGMENTIN 375)
T-AMOXYCILLIN 500MG + CLAYULANIC ACID 125MG (AUGMENTIN 625)
T-ANASTROZOLE (ARIMIDEX) 1MG
T-ARCOLVIT (NEUTROSEC FORMULA)
T-ARTESUNATE 50MG
T-ATORVASTATIN 10MG
T-AZATHIOPRINE 50MG
T-BISOPROLOL FUMERATE 5MG
230
T-CAL. CARB. 1250MG EQV TO ELEMENTAL CAL. 500MG + VIT D3 250IU (SHELCAL
500MG FORMULA)
231
T-CALCIUM CITRATE EQV TO ELEMENTAL CALCIUM 200MG, ZINC SULP. 4MG,
MONOHYDRATE MAGNESIUM HYDROXIDE 50MG, VIT D3 200IU (MILICAL XP)
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
T-CAPECITABINE 500MG (XELODA)
T-CARBAMAZEPINE 400MG CR
T-CARBIMAZOLE 5MG (NEOMERCAZOLE)
T-CARVEDILOL 12.5MG
T-CARVEDILOL 3.125MG
T-CARVEDILOL 6.25MG
T-CEFIXIME 200MG+LACTIC ACID 60MIL.
T-CEFUROXIME 250MG (CEFTUM)
T-CEFUROXIME 500MG
T-CINNARIZINE 25MG (STUGERON )
T-CLOBAZAM 10MG (FRISIUM)
T-CLOBAZAM 5MG(FRISIUM)
T-CLONAZEPAM 0.5MG(RIVOTRIL)
T-CLONAZEPAM 1MG
T-CONJUGATED OESTROGEN 0.625(PREMARIN)
247
248
249
250
251
252
253
T-DAFLON 500MG (MICRONISED PURIFIED FLAVONOID FRACTION OF RUTACEAE
500MG)
T-DEFERASIROX 100MG (ASUNRA)
T-DEFERASIROX 400MG (ASUNRA)
T-DIDROGESTRONE 10MG(DUPHASTON)
T-DIGOXIN 0.25MG
T-DILTIAZEM 120MG SR
T-DILTIAZEM SR 90MG
254
T-DIOVOL FORMULA (DR. AL. HUD. GEL 240MG+MG. HY. 100MG+MAG.CARBONATE
60MG+ACTIVATED DIMETHICONE 25MG
255
256
257
T-DROTAVERINE 80MG
T-EBASTINE 20MG(EBAST)
T-ECOSPORIN 325MG (ACETYL SALICYLIC ACID 325MG)
Page 22 of 29
258
259
260
261
262
263
264
265
T-ENALAPRIL MALEATE 2.5MG
T-ESCITALOPRAM 10MG
T-ESCITALOPRAM 20MG
T-ETHAMSYLATE 250MG
T-ETHAMSYLATE 500MG
T-ETHIONAMIDE 250MG
T-ETOPHYLLIN 77MG +THEOPHYLLIN 23MG(DERIPHYLLINE PLAIN)
T-FAMOTIDINE-40MG
266
T-FERROUS CALCIUM CITRATE 278MG EQV TO 25MG IRON, 36MG CALCIUM, 0.3MG
FOLIC ACID
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
T-FLUTAMIDE 250MG
T-GABAPENTINE 300MG
T-GABAPENTINE 400MG
T-GAFTINET 250MG
T-GLICLAZIDE MR 60MG (DIAMICRON)
T-GLYBENCLAMIDE-5MG(BETANASE)
T-HALOPERIDOL 1.5MG
T-HALOPERIDOL 5MG
T-HYDROXY UREA 500MG
T-HYDROXYZINE HCL 25MG(ATAREX)
T-ISOSORBIDE MONONITRATE 30MG SR (IMDURE 30MG SR)
T-ISOSORBIDE MONONITRATE 60MG SR (IMDURE 60MG SR)
T-ITRACANAZOLE 100MG
T-IVABRADINE 5MG(CORALAN)
T-LAPATINIB 250MG(TYKERB)
T-LETROZOLE 2.5MG
T-LEVAMISOLE-150MG(DECARIS)
T-LEVONORGESTREL 75MG
T-LOSARTAN 25MG
T-LOSARTAN 50MG
T-LOSARTAN 50MG+ HYDROCHLORTHIAZIDE 12.5MG
T-MECLIZINE HCL 25MG + CAFFEINE 20MG (PREGNIDOXIN)
T-MEFTAL SPAS(DICYCLOMINE 10MG, MEFANAMIC ACID 250MG)
T-MESACOL (MESALAZINE 5-AMINOSALICYLIC ACID-400MG)
T-MESTEROLONE 25(PROVIRONUM)
T-METADOXINE 500MG(METADOXIL)
T-METAPROLOL TARTRATE 50MG
T-METHOTREXATE 2.5MG
T-METHYL PREDNISOLONE 16MG (MEDROL)
T-METOLAZONE 5MG
T-MIFEPRISTONE 200MG
T-MYCOPHENOLATE MOFETIL 500 (CELLCEPT)
T-NICORANDIL 10MG (NIKORAN)
Page 23 of 29
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
T-NIFEDIPINE SR 20MG (DEPIN RETARD)
T-NITRAZEPAM-5MG(NITRAVIT)
T-OLANZAPINE 2.5MG
T-ONDANSETRON 4MG(EMESET )
T-ORNIDAZOLE 500MG
T-PAROXETINE 10MG
T-PAROXETINE 20MG
T-PERINDOPRIL 2MG (COVERSYL)
T-PERINDOPRIL 4MG (COVERSYL)
T-PERINDROPIL 4MG + AMLODIPINE 5MG (COVERSYL AM)
T-POVIDONE VAGINAL 200MG (BETADINE VAGINAL)
T-PREDNISOLONE 10MG
T-PROCHLORPERAZINE-5MG(STEMETIL)
T-PYRAZINAMIDE 1000MG
T-PYRIDOXINE HCL 100MG(B-LONG)
T-RABEPRAZOLE 20MG
T-RESPERIDONE 1MG
T-SECNIDAZOLE 1GM
T-SERTRALINE 50MG
T-SEVELAMER 400MG(SEVAGEL)
T-SOD.VALPORATE-200MG
T-TELMISARTAN 40MG
T-TERAZOCIN 2MG
T-TERBUTALINE SULPHATE 5MG
T-THEOPHYLLIN CR 200MG
T-THIOCOLCHICOSIDE 4MG +DICLOFENAC SODIUM 50MG
T-THYROXINE SODIUM 50MCG
T-TIANEPTINE SOD.12.5MG(STABLON)
T-TIZANIDINE 2MG(SIRDALUD)
T-TOLPERISONE HCL JPC 450MG
T-TRIAMTERINE 50MG + BENZTHIAZIDE 25MG (DITIDE)
T-TRIHEXYPHENIDYL 2MG (PACITANE)
T-TRYPSIN CHYMOTRYPSIN 1 LAC UNITS (CHYMORAL FORTE)
T-VALSARTAN 80MG (VALZAAR 80)
T-ZOLPIDEM 10MG
T-ZOLPIDEM 5MG(NITREST)
T-DOXYFYLLINE 400MG
N-LEVOSALBUTAMOL TART.50MCG INHALER
T-NEBIVOLOL 2.5MG (NEBICARD)
T-NEBIVOLOL 5MG (NEBICARD)
T-TELMISARTAN 40MG, AMLODIPINE 5MG
T-INDAPAMIDE SR 1.5MG, AMLODIPINE 5MG
T-ETORICOXIB 90MG
Page 24 of 29
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
C-DICLOFENAC COLESTYRAMINE 145.6MG (DICLOFENAC RESINATE)
C-TOLFENAMIC ACID 200MG(CLOTAN)
T-ZOLPIDEM TART.6.25MG(STILNOCT)
T-LITHIUM CARBONATE 150MG
T-SERTRALINE 25MG
T-TAMSULOSINE 0.4MG (URIMAX)
T-TIBOLONE 2.5MG(LIVIAL)
T-ETHINYLESTRADIOL 0.02 + DESOGESTREL 0.15MG
T-DESOGESTREL 75MCG(LOW DOSE PROGESTRONE ORAL PILL)(CERAZETTE)
T-BETAMETHASONE 1MG
T-GLIPIZIDE 5MG (GLYNASE)
T-VOGLIBOSE 0.2MG
T-SITAGLIPTINE 50+METFORMIN 500MG (JANUMET)
T-SITAGLIPTINE 50 + METFORMINE 1000MG (JANUMET)
T-VILDAGLIPTINE 50 + METFORMIN 500MG
T-VILDAGLIPTIN 50 + METFORMIN 1000MG
T-CLINDAMYCIN 300MG
T-SEBIVO 600MG (TELBIVUDINE)
T-DAPSONE-100MG
C-EVION-400MG( VITAMIN E 400MG)
363
T-BEPLEX FORTE (THIAMINE MONONITRATE 10MG, RIBOFLAVIN 10MG, NICOTINIC
ACID 25MG, NIACINAMIDE 75MG, PYRIDOXIN HCL. 3MG, CAL. PENTOTHENATE 50MG,
FOLIC ACID 1.5MG, VIT.B-12 15MCG, VIT.C 150MG, BIOTIN 260MCG, LIGHT
MAGNESIUM OXIDE EQV. TO ELEMENTAL MAGNESIUM 32.4MG)
364
365
366
367
368
369
370
371
372
373
374
375
T-CALCIUM & MINERALS (CALCIUM CARBONATE 1000MG FROM ORGANIC SOURCE
(OYSTER SHELL) EQV. TO ELEMENTAL CALCIUM 400MG, HEAVY MAGNESIUM OXIDE
150MG EQV. TO ELEMENTAL MAGNESIUM 90MG, ZINC SULPHATE MONOHYDRATE
13.75MG EQV. TO ELEMENTAL ZINC 5MG, L-LYSINE HCL 100MG, PYRIDOXINE HCL
1.5MG, CHOLECALCIFEROL 200IU)
C-TRIPLE A CAL OS (ELEMENTAL CALCIUM 150MG IN THE FORM OF CAL. HYDOXIDE
& CAL. OXIDE PRETREATED WITH HEATED ALGAE, ZINC SULPHATE MONOHYDRATE
EQV. TO ELEMENTAL ZINC 7.5MG, CALCITRIOL 0.25MCG.)
C-IMATINIB 400MG
T-TACROLIMUS 1MG
T-ERLOTINIB 100(TARCEVA)
C-NILOTINIB 200(TASIGNA)
I-DICYCLOMINE 20MG, DICLOFENAC SODIUM 50MG
O-PROTOCREAM 20GM TUBE
I-OMALIZUMAB 150MG(XOLAIR)
N-BUDESONIDE 1MG RESP. SOLN.2ML.
I-DILTIAZEM
I-FACTOR VIII BYPASSING ACTIVITY, ANTI INHIBITOR-COAGULANT COMPLEX 500IU
Page 25 of 29
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
I-RECOMBINANT HEMOPHILLIC FACTOR VIII 250 IU
I-RECOMBINANT HEMOPHILLIC FACTOR VIII 500 IU
I-RECOMBINANT HEMOPHILLIC FACTOR VIII 1000 IU
I-SYNVISC ONE (HYLAN G-F20)
I-ACTEMRA 80MG (TOCILIZUMAB)
I-ACTEMARA 200MG (TOCILIZUMAB)
I-ACTEMRA 400MG (TOCILIZUMAB)
I-HUMAN INSULIN (50%SOL+50%NPH)
I-INSULIN LISPRO 100IU/ML (HUMALOG)
I-CLINDAMYCIN 600MG
I-TIGECYCLINE 50MG(TEVRAN)
I-TOBRAMYCIN 20MG
I-TOBRAMYCIN 60MG
I-TOBRAMYCIN 80MG
I-AMPHOTERICIN B 50MG
I-ACYCLOVIR 500MG/VIAL
392
O-CHLORAMPHENICOL 1% INPLIABLE GELATIN CAPS. WITH ELONGATED TIP EYE
APPLICAP
D-BETAMETHASONE SOD. PHOS. 1% EYE DROPS
D-HOMATROPINE HYDROBROMIDE 2% EYE DROPS
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
D-DEXAMETHASONE SOD. PHOSPHATE 0.1%, NEOMYCIN SULPHATE
BENZALKONIUM CHLORIDE IN ISOTONIC SOLN. 0.02% EYE DROPS
0.5%,
D-MOISOL EYE DROPS (HYDROXYPROPYL METHYL CELLULOSE 0.7%, BORAX 0.19%,
BORIC ACID 0.19%, SOD. CHLORIDE 0.45%, POT. CHLORIDE 0.37%, BENZALKONIUM
CHLORIDE 0.01%)
O-CIPROFLOXACIN 0.3% W/W EYE OINT.
D-OFLOXACIN 0.3%,PRED.ACETATE 1%
I-LUCENTIS (RANIBIZUMAB 10MG)
D-NEOSPORIN H EAR DROPS (POLYMYXIN B SULPHATE 10000IU, NEOMYCIN
SULPHATE 3400IU, HYDROCORTISONE 10MG W/W)
N-BECLATE NASAL SPRAY (BECLOMETHASONE DIPROPIONATE 50MCG)
N-AZELASTINE 0.05% NASAL SPRAY
O-TRIAMCINOLONE ACETONIDE 0.1 OINT.
O-AZELAIC ACID 10% CREAM (AZIDERM)
I-ROCURONIUM 50MG
I-VITAMIN D3 3LAC IU PER AMP.
I-HAEMO DIALASIS FLUID(AT-CITRATE
I-FRUCTODEX WATER(INVERT SUGER 10G.
I-FRUCTODEX SALINE
I-BORTEZOMIB 1MG(VELCADE)
I-BORTEZOMIB 3.5MG(VELCADE)
I-CABAZITAXEL 60MG(JEVTANA)
I-HEPATITIS B IMMUNOGLOBULIN 100IU
Page 26 of 29
414
S-SUCRALFATE100,OXETACAINE 20MG /10ML
415
P-PRE & PROBIOTIC & ORAL REHYDRATION (BIORS SACHET) WHO ORS PACK 4.10G. CONTAINS:
SOD.CHLORIDE 0.52G, SOD. CIRATE 0.58G, POT.CHLORIDE 0.3G, DEXTROSE ANHYDROUS 2.7G & PRE &
PROBIOTIC PACK 0.5G CONTAINS: STREPTOCOCCUS FAECALIS T-110 7.5MILLION, CLOSTRIDIUM
BUTYRICUM TO-A 0.5MILLION, BACILLUS MESENTERICUS TO-A 0.25 MILLION, LACTOBACILLUS
SPOROGENES 20 MILLION)
416
417
418
419
420
421
422
423
S-AMBRODRY
S-DIGOXIN SYP.
S-ENTECAVIR 0.05MG PER ML (BARACLUDE)
S-RIFAMPICIN-100MG/5ML
L-MOMETASONE FUROATE 0.1% LOTION (MOMATE)
B-PAPER ADH. TAPE 2.5CMX9.14M
B-PAPER ADH. TAPE 5CMX9.14M
B-FERACRYLUM 3% DRESSING(SEPGARD TULLE COTTON)
424
S-HEPATOGLOBINE MIKROS (PEPTONISED IRON 176.5MG EQV. TO 30MG OF
ELEMENTAL IRON, PROTEIN AS PEPTONE 100MG, FA 200MCG, VITAMIN B12 2.5MCG)
Page 27 of 29
ANNEXURE-B
PRE-RECEIPT
Received Rs_______________(Rupees_____________)towards refund of
Earnest money vide Challan No________________ Dated__________
in respect of tender for Testing of Drug dated______________.
(Signature of the bidder with stamp)
Page 28 of 29
Annexure “c”
BENEFICIARY’S
1.
2.
3.
4.
5.
6.
7.
8.
9.
MANDATE FORM
OPTION TO RECEIVE PAYMENT THROUGH
e-PAYMENT
BENEFICIARY NAME
BENEFICIARY ADDRESS
BENEFICIARY ACCOUNT NO.
ACCOUNT TYPE (S.B. ACCOUNT/CURRENT
ACCOUNT FOR CASH CREDIT) WITH
CODE 10/11/13
9 DIGIT CODE NUMBER OF THE BANK & BRANCH
APPEARING ON THE MICR CHEQUE ISSUED BY
BANK NAME
BANK NAME
ADDRESS
TELEPHONE NO.
IFSC (INDIAN FIANANCIAL SERVICE CODE)
PHOTOCOPY OF CANCELLED CHEQUE TO CONFIRM
CORRECTNESS OF IFSC CODE AND ACCOUNT NO.
GIVEN IN C & H
I, HEREBY, DECLARE THAT THE PARTICULARS GIVEN ABOVE ARE CORRECT
AND COMPLETE. IF THE TRANSACTION IS DELAYED OR NOT EFFECTED AT
ALL FOR REASON OF INCOMPLETLE ON INCORRECT INFORMATION GIVEN BY
ME AS ABOVE, I WOULD NOT HOLD THE USER INSTITUTION RESPONSIBLE.
DATED ___________
(___________________________)
SIGNATURE OF THE BENEFICIARY/CUSTOMER
CERTIFIED THAT THE PARTICULATES FURNISHED ABOVE ARE CORRECT AS
PER OUR RECORDS.
BANK’S STAMP
DATE ________________
(___________________________)
SIGNATURE OF THE AUTHORISED/OFFICIAL
Page 29 of 29
Annexure-V
Date ______________
UNDERTAKING
I/WE undersigned is /are authorized signatory/signatories of the firm
M/s ___________________________ Address
_________________________________________ do here by undertake that
1. The firm is in this business in continuation from
Year 2010 .
2. If any information in the tender submitted by me is found
incorrect/false at any time Tender is liable to be rejected.
Authorized signatory
(With rubber stamp)